Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the ...
GlobalData on MSN5d
Median Technologies secures €47.5m to commercialise cancer diagnosticUp to €37.5m of Median’s funding comes from the EIB, and €10m from an equity line with IRIS Capital Investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback